Five points:
1. People with common allergies aren’t more likely than the general public to have a reaction to the mRNA vaccines.
2. The vaccine should be administered at a place where anaphylaxis can be recognized and treated.
3. Anyone who gets an mRNA COVID-19 vaccine should stay on-site for 15 to 30 minutes after getting the shot to monitor for a reaction.
4. Data on risk in those with a history of allergic reaction to other vaccines is limited and evolving.
5. Anyone who has a severe allergic reaction to the first dose of the vaccine shouldn’t get the second one.
Read more here.
More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don’t
Stryker’s ASC-focused business: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
